FDA Adverse Event Injury Summary report: N

DEXCOM G6 CONTINUOUS GLUCOSE MONITORING SYSTEM

MDR report key: 15287477 · Received August 24, 2022

Report

Report Number
3004753838-2022-155680
Event Type
Injury
Date Received
August 24, 2022
Date of Event
August 1, 2022
Report Date
August 24, 2022
Manufacturer
DEXCOM, INC.
Product Code
QBJ
PMA / PMN Number
DEN170088
Adverse Event
Yes
Product Problem
Yes
Report Source
Manufacturer report
Reporter Location
DE
Reporter Occupation
OTHER

Narratives

Additional Manufacturer Narrative · 0

(B)(4). INITIAL REPORTER EMAIL ADDRESS: (B)(6). DIABETES MELLITUS IS A KNOWN CAUSE OF HYPOGLYCEMIA.

Description of Event or Problem · 0

IT WAS REPORTED THAT THE PEDIATRIC PATIENT EXPERIENCED A HYPOGLYCEMIC EVENT. THE SENSOR WAS INSERTED INTO THE ARM ON (B)(6) 2022. ON (B)(6) 2022, THE PATIENT LOST THE DEXCOM SENSOR WITHOUT NOTICING DUE TO THE POOR PATCH ADHESION, AND THE PARENT INDICATED THAT THEREFORE THE T-SLIM INSULIN PUMP DID NOT RECEIVE ANY INFORMATION AND KEPT RELEASING INSULIN. ABOUT FIVE MINUTES AFTER EVENTUALLY NOTICING THE PATCH ISSUE THE PATIENT BECAME SYMPTOMATIC FOR HYPOGLYCEMIA, BECAME SHORT OF BREATH, AND HAD A SEIZURE. NO BLOOD GLUCOSE (BG) VALUE AT THIS TIME WAS REPORTED AND IT IS UNKNOWN WHAT THE INSULIN PUMP WAS DISPLAYING. THE PATIENT'S MOTHER TREATED THE PATIENT WITH BAQSIMI (GLUCAGON NASAL POWDER) AND PROVIDED UNSPECIFIED FIRST AID TO THE PATIENT WHILE THE EMERGENCY PERSONNEL WAS ARRIVING. THE BG WAS 70 MG/DL AFTER THE FIRST AID TREATMENT. THE EMERGENCY PERSONNEL TOOK THE PATIENT TO THE HOSPITAL AND HE WAS HOSPITALIZED FOR SEVEN DAYS. NO INFORMATION WAS DOCUMENTED ABOUT THE TREATMENT PROVIDED DURING THE HOSPITALIZATION. THE PATIENT RECOVERED AND AT THE TIME OF THE REPORT WAS DOING FINE. NO PRODUCT WAS PROVIDED FOR EVALUATION. THE COMPLAINT CONFIRMATION WAS UNABLE TO BE DETERMINED. THE PROBABLE CAUSE WAS NOT DETERMINED. NO ADDITIONAL PATIENT OR EVENT INFORMATION IS AVAILABLE.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
439765 DEXCOM G6 CONTINUOUS GLUCOSE MONITORING SYSTEM CONTINUOUS GLUCOSE MONITOR QBJ DEXCOM, INC. NI NI

Patients

Seq Age Sex Outcome Treatment
1 17 YR Male Other| H